| Literature DB >> 15878100 |
Borut Kragelj1, Lijana Zaletel-Kragelj, Boris Sedmak, Tanja Cufer, Jozica Cervek.
Abstract
Concurrent vinablastine-based radiochemotherapy was evaluated in 84 bladder-cancer patients. It was effective in more than half: tumour-specific survival (51% 9-year), local control rate (55% 9-year). The drawback was the impaired function of the bladder (9-year prevalence SOMA G3-4 symptoms: 66%), indicating the need for treatment aimed at reducing chronic morbidity.Entities:
Mesh：
Substances：
Year: 2005 PMID： 15878100 DOI： 10.1016/j.radonc.2005.01.007
Source DB: PubMed Journal: Radiother Oncol ISSN： 0167-8140 Impact factor: 6.280